Expedeon Ltd. is a global provider of innovative technologies and services for the life sciences and diagnostics industries. The company’s core technologies, innovative products and services are used in research laboratories around the world, enabling scientists to push the boundaries of research and product development, and play an integral part in new diagnostic tools being brought to market. Expedeon has offices in Germany, Spain, UK, USA and Singapore and its products are sold through a direct sales force and several distribution partners in Europe, the USA and Asia.
Partnership with Sona
Sona and Expedeon have signed a distribution and development agreement for the supply of Sona’s unique gold nanorods for integration into Expedeon’s product range. Following evaluation of the quality and sensitivity of Sona’s gold nanorods, Expedeon decided to include their Gemini and Omni products within their complete range of gold nanoparticles and conjugation technologies.
Under the terms of the agreement, Expedeon is committed to promote and market the nanorods to life science researchers and diagnostic companies around the world via its extensive distribution network and strong direct sales channels.
The company will invest in R&D to incorporate Sona’s technology into its comprehensive product range coupled with its own proprietary technologies. Expedeon will also provide a referral service for lateral flow assay contract developments, laying the foundations for future growth.
The partnership will open access to new markets, new technologies and new lateral flow test developers for Sona to collaborate with and develop next generation lateral flow assays. To have Sona’s products integrated into the Expedeon product line is a huge milestone as we continue to work towards our goal of becoming a global life sciences brand.
- Press release: Distribution and development agreement signed between Sona Nanotech Inc. and Expedeon
25 Norman Way, Over, Cambridge, CB24 5QE